Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known?
- PMID: 32765712
- PMCID: PMC7401831
- DOI: 10.3892/etm.2020.8808
Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known?
Abstract
In 2020 a new pandemic caused by the SARS-CoV-2 coronavirus is affecting the lives of millions of patients and healthcare workers worldwide. The clinical picture of this infection is in a dynamic process of discovery, and more symptoms emerge as the clinicians observe and diagnose manifestations that affect multiple organs. Anosmia (loss of smell), and ageusia (loss of taste) become more frequently cited as independent symptoms or in association with the most common manifestations of the disease, such as fever, cough and dyspnea. A thorough screening program will prevent most nosocomial and community-acquired infections by promoting efficient triage and specific measures such as isolation of the patients. Therefore, it is important to include frequent symptoms in the anamnesis and questionnaires to select those patients who might benefit from testing, isolation, and treatment. This study summarizes the existing data regarding the association of anosmia and ageusia with the SARS-CoV-2 infection. It also aims to describe manifestations of these, particularly in the clinical picture of all symptomatic patients.
Keywords: COVID-19; SARS-CoV-2; ageusia; anosmia; coronavirus.
Copyright: © Tanasa et al.
Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 20;5:CD013665. doi: 10.1002/14651858.CD013665.pub3. PMID: 33620086 Free PMC article. Updated.
-
Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.Int J Environ Res Public Health. 2022 Jan 18;19(3):1047. doi: 10.3390/ijerph19031047. Int J Environ Res Public Health. 2022. PMID: 35162068 Free PMC article.
-
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.Sci Rep. 2022 May 4;12(1):7249. doi: 10.1038/s41598-022-11103-0. Sci Rep. 2022. PMID: 35508524 Free PMC article.
-
Simultaneously complete but not partial taste and smell losses were associated with SARS-CoV-2 infection.Int J Infect Dis. 2021 May;106:329-337. doi: 10.1016/j.ijid.2021.03.083. Epub 2021 Apr 2. Int J Infect Dis. 2021. PMID: 33819604 Free PMC article.
-
Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.Compr Psychiatry. 2020 Jul;100:152184. doi: 10.1016/j.comppsych.2020.152184. Epub 2020 May 11. Compr Psychiatry. 2020. PMID: 32422426 Free PMC article. Review.
Cited by
-
Stress-Induced Cardiomyopathy-Considerations for Diagnosis and Management during the COVID-19 Pandemic.Medicina (Kaunas). 2022 Jan 27;58(2):192. doi: 10.3390/medicina58020192. Medicina (Kaunas). 2022. PMID: 35208516 Free PMC article. Review.
-
Physicians' Perspectives on COVID-19: An International Survey.Healthcare (Basel). 2020 Aug 2;8(3):250. doi: 10.3390/healthcare8030250. Healthcare (Basel). 2020. PMID: 32748880 Free PMC article.
-
COVID-19: Invasion, pathogenesis and possible cure - A review.J Virol Methods. 2022 Feb;300:114434. doi: 10.1016/j.jviromet.2021.114434. Epub 2021 Dec 14. J Virol Methods. 2022. PMID: 34919978 Free PMC article. Review.
-
SARS-CoV-2 infection and diabetes mellitus: A North Eastern Romanian experience.Exp Ther Med. 2021 Mar;21(3):279. doi: 10.3892/etm.2021.9710. Epub 2021 Jan 25. Exp Ther Med. 2021. PMID: 33603886 Free PMC article.
-
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.Orphanet J Rare Dis. 2021 May 6;16(1):204. doi: 10.1186/s13023-021-01834-0. Orphanet J Rare Dis. 2021. PMID: 33957949 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous